These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24980509)

  • 1. Metabolic and transcriptional activities of Staphylococcus aureus challenged with high-doses of daptomycin.
    Lechner S; Prax M; Lange B; Huber C; Eisenreich W; Herbig A; Nieselt K; Bertram R
    Int J Med Microbiol; 2014 Nov; 304(8):931-40. PubMed ID: 24980509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between population dynamics and drug tolerance of Staphylococcus aureus persister cells.
    Lechner S; Patra P; Klumpp S; Bertram R
    J Mol Microbiol Biotechnol; 2012; 22(6):381-91. PubMed ID: 23363876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel point mutation promotes growth phase-dependent daptomycin tolerance in Staphylococcus aureus.
    Mechler L; Herbig A; Paprotka K; Fraunholz M; Nieselt K; Bertram R
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5366-76. PubMed ID: 26100694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus Persisters.
    Prax M; Mechler L; Weidenmaier C; Bertram R
    PLoS One; 2016; 11(3):e0150907. PubMed ID: 26960193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcus aureus persisters tolerant to bactericidal antibiotics.
    Lechner S; Lewis K; Bertram R
    J Mol Microbiol Biotechnol; 2012; 22(4):235-44. PubMed ID: 22986269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.
    Torrico M; Aguilar L; Sevillano D; Giménez MJ; Alou L; González N; Cafini F; Cleeland R; Prieto J
    Int J Antimicrob Agents; 2011 Apr; 37(4):332-8. PubMed ID: 21388792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial mechanism of daptomycin antibiotic against Staphylococcus aureus based on a quantitative bacterial proteome analysis.
    Ma W; Zhang D; Li G; Liu J; He G; Zhang P; Yang L; Zhu H; Xu N; Liang S
    J Proteomics; 2017 Jan; 150():242-251. PubMed ID: 27693894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of daptomycin activity against Staphylococcus aureus in an in vitro pharmacodynamic model under normal and simulated impaired renal function.
    Huang V; Rybak MJ
    J Antimicrob Chemother; 2006 Jan; 57(1):116-21. PubMed ID: 16311369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
    Appleman MD; Citron DM
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
    J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.
    Begic D; von Eiff C; Tsuji BT
    J Antimicrob Chemother; 2009 May; 63(5):977-81. PubMed ID: 19304733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
    Sader HS; Becker HK; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):329-31. PubMed ID: 20159377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin.
    Brinch KS; Tulkens PM; Van Bambeke F; Frimodt-Møller N; Høiby N; Kristensen HH
    J Antimicrob Chemother; 2010 Aug; 65(8):1720-4. PubMed ID: 20534628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.
    Patel D; Husain M; Vidaillac C; Steed ME; Rybak MJ; Seo SM; Kaatz GW
    Int J Antimicrob Agents; 2011 Nov; 38(5):442-6. PubMed ID: 21840181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.
    Entenza JM; Giddey M; Vouillamoz J; Moreillon P
    Int J Antimicrob Agents; 2010 May; 35(5):451-6. PubMed ID: 20185277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization.
    Muthaiyan A; Silverman JA; Jayaswal RK; Wilkinson BJ
    Antimicrob Agents Chemother; 2008 Mar; 52(3):980-90. PubMed ID: 18086846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
    Saravolatz LD; Pawlak J; Johnson LB; Saravolatz LD; Husain N
    Int J Antimicrob Agents; 2010 Nov; 36(5):478-80. PubMed ID: 20846830
    [No Abstract]   [Full Text] [Related]  

  • 19. Daptomycin Tolerance in the Staphylococcus aureus pitA6 Mutant Is Due to Upregulation of the dlt Operon.
    Mechler L; Bonetti EJ; Reichert S; Flötenmeyer M; Schrenzel J; Bertram R; François P; Götz F
    Antimicrob Agents Chemother; 2016 May; 60(5):2684-91. PubMed ID: 26883712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin non-susceptible Staphylococcus aureus at a US medical centre.
    Velazquez A; DeRyke CA; Goering R; Hoover V; Wallace MR
    Clin Microbiol Infect; 2013 Dec; 19(12):1169-72. PubMed ID: 23480569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.